UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Lilly’s anticancer combo drug nears getting insurance benefit
by Kim Yun-mi
2019-08-07 15:44
Japanese firms fear boycott may hurt prescription drug sales
by Kim Yun-mi
2019-08-06 15:44
Roche, MSD, AstraZeneca: top 3 risers on NASDAQ biotech
by Kim Yun-mi
2019-08-06 11:29
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
by Kim Yun-mi
2019-08-05 15:37
‘MSD Korea playing tricks to maintain monitoring on salespersons’
by Kim Yun-mi
2019-08-02 15:48
라인
Conflict erupts between employees of Takeda, Shire during merger
by Kim Yun-mi
2019-08-02 14:23
‘Recurrent chronic lymphocytic leukemia needs various treatment options’
by Kim Yun-mi
2019-08-01 15:31
Novartis fails to expand heart failure drug Entresto’s indication
by Kim Yun-mi
2019-07-31 14:26
‘FDA likely to OK 11 blockbuster candidates in August’
by Kim Yun-mi
2019-07-29 16:55
Takeda’s Zejula poised to change local ovarian cancer treatment market
by Kim Yun-mi
2019-07-29 12:04
라인
Will Gilead enter the autoimmune diseases market?
by Kim Yun-mi
2019-07-22 17:34
Employees file suit against Galderma Korea
by Kim Yun-mi
2019-07-19 15:41
2 cancer immunotherapy makers face different situations in reimbursement talks
by Kim Yun-mi
2019-07-18 16:01
Korean pulmonary arterial hypertension patients’ survival far lower than Japanese
by Kim Yun-mi
2019-07-15 16:48
Humira permitted for nursing, pregnant patients
by Kim Yun-mi
2019-07-11 16:41
라인
‘Patients with myeloproliferative neoplasm unaware of cause before diagnosis’
by Kim Yun-mi
2019-07-02 16:42
BMS Korea files administrative suit to appeal Eliquis price cut
by Kim Yun-mi
2019-07-01 14:16
Lilly anticipates Trulicity’s growth as GLP-1 receptor antagonists get popular
by Kim Yun-mi
2019-06-28 16:12
Why people still ask if AIDS is preventable
by Kim Yun-mi
2019-06-26 17:02
‘Imbruvica raised survival rate of mantle cell lymphoma patients’
by Kim Yun-mi
2019-06-25 15:34
-
이전
11
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top